Diabetes Diagnostics Market: About the Report
Demand for diabetes diagnostics is expected to rise in response to surging hospitalizations amid the COVID-19 surge. Studies identifying diabetics at higher risk of getting critically ill if infected by the virus are fuelling demand for various related products, including diabetes test strips. Fact.MR, in its recent report, has projected that demand from hospitals will continue increasing through the forecast period from 2020 and 2030. Government funding towards building hospitals to make healthcare better accessible in rural areas will aid overall expansion of the market. North America, Asia Pacific, and Europe will be attractive regions for players in the global diabetes diagnostics market through 2030.
Diabetes Diagnostics Market Overview
Driven by the increasing incidence of diabetes, the global diabetes diagnostics market is exhibiting notable growth. According to the World Health Organization (WHO), 422 million people around the world have diabetes. Prevalence of diabetes is higher in low- and middle-income countries, as per the WHO’s findings. Besides this, diabetes also is identified as a principal reason behind rising kidney failure, blindness, heart attacks, stroke, and lower limb amputation cases.
According to Fact.MR, the rising incidence of diabetes is expected to fuel the demand for better-performance and smarter diabetes diagnostics to increase significantly between 2020 and 2030.As per the WHO, globally, over 1.9 billion adults aged 18 years and older were overweight in 2016. Of these, more than 650 million adults were obese. Obesity is known to be one of the key conditions that can lead to diabetes. Higher prevalence of obesity will therefore stoke growth opportunities for the diabetes diagnostics market.
Advent of Nanotechnology Propelling Growth
Nanotechnology is at the forefront of technologies that are forecast to offer a reliable methodology in the early and precise diagnosis and treatment of diabetes. Several benefits of nanotechnology, such as drug release control and target specification, are driving experts to develop advanced glucose detection and insulin delivery methods using nanotechnology. Such advancements are likely to boost the growth of the global diabetes diagnostics market.
Nanotechnology gives access to advanced sensing technologies to provide timely and more accurate information on diabetes. A pair of researchers from the Oregon State University College of Engineering developed means to print transistor-based glucose sensors onto a catheter attached to a wearable pump. This technology allowed diabetics to program the pump to deliver glucagon and insulin at precise doses and time.
A slew of studies similar the one mentioned are undertaken in the last few years to study the use of nanotechnology in diabetes. A common aim of these researches is to offer timely and accurate diagnosis. Spurred by this, the diabetes diagnostics market will exhibit significant growth over the coming years.
Lack of Awareness Limiting Market Growth
The diabetes diagnostics market is hampered by lack of awareness about diabetes and its effects. In 2015, according to UK National Health Service (NHS), nearly 3.9 million people were diagnosed with diabetes, and more than 590,000 people were unaware and undiagnosed. This might restrict the overall growth opportunities for the market.
Regional Outlook of Diabetes Diagnostics Market
North America is one of the most attractive markets for diabetes diagnostics. Rising healthcare expenditure is one of the biggest factors accountable for the region's exceptional growth. For instance, in 2019, Canada's per-capita spending on health ranked 11th amongst health-care systems in the Organization for Economic Co-operation and Development (OECD). Besides this, increasing Food and Drug Administration (FDA) approvals to some of the leading market players in countries such as the U.S. and Canada are also boosting the growth of the diabetes diagnostics market in North America. For instance, in February 2020, Abbott obtained FDA permission for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals and clinics.
Asia Pacific has also emerged as a lucrative market for diabetes diagnostics. Rising diabetic population in economies such as China and India is driving growth in the region. Increasing government funds, initiatives, and education on health awareness are further augmenting the demand for diabetes diagnostics in the region. For instance, the New Rural Co-operative Medical Care System (NRCMCS) is intended at making the healthcare system more affordable for rural people in China. It covered nearly 98% of rural residents in 2018. Such initiatives towards the developing healthcare sector in underdeveloped areas of the developing countries are promoting diabetes diagnostics market growth.
Besides North America and Asia Pacific, Europe accounts for a sizeable share of the global diabetes diagnostics market. Growth witnessed in the region is primarily due to the growing diabetes cases in the region. According to the WHO, deaths caused due to diabetes are expected to double by 2030 as compared to 2005. Furthermore, increasing projects towards the expansion of healthcare are likely to augment market growth. For instance, the NOVEL project is intended to transform healthcare in Europe. The European Union's Horizon 2020 funded the NOBEL Coordination and Support Action. Such projects are expected to fuel demand for smarter diabetes diagnostics during the forecast period.
Diabetes Diagnostics Market Insights by Product
According to Fact.MR, the test strips segment is forecast to witness surging demand during the assessment period, in terms of product in the diabetes diagnostics market space. Test strips manufacturers are increasingly launching low-cost products. Besides this, rising investment is propelling growth within the segment. For instance, In June 2018, LaunchByte, an investment company, invested in StripSupply, a Boston-based blood glucose testing Product Company. This investment helped StipSupply in stimulating the development of low-cost test strips, and their production and sales.
Besides this, the continuous glucose monitors (CGM) segment is also expected to showcase noteworthy growth owing to the development of smarter CGMs. Moreover, the growing interest of players in collaborations is also supporting the growth of this segment. For instance, Medtronic Plc partnered with Eris Lifesciences to produce a smart continuous glucose monitoring system in January 2019.
Diabetes Diagnostics Market Insights by End User
Based on end user, hospitals are likely to account for a sizeable share of the market in terms of market value. Growing number of hospitals and the rising number of facilities across the world are key factors behind the growth of this segment.
Besides, rising government expenditure on healthcare is augmenting the demand for diabetes diagnostics in hospitals and among other end users. For instance, according to National Health Expenditure Accounts (NHEA), health care spending in the U.S. grew 4.6 percent in 2019 and reached $3.8 trillion or $11,582 per person. Such rising spending coupled with increasing healthcare awareness is driving more patients to diabetes diagnosis, which is benefitting the market.
Diabetes Diagnostics Market: Competitive Landscape
The market for diabetes diagnostics is getting extremely competitive owing to the rising cases of around the world and increasing willingness among patients to spend on advanced healthcare. With rising number of new entrants in the diabetes diagnostics market, established players are focusing on technological advancement and frequent new product launches to maintain their positions.
For instance, in June 2018, Senseonics gained FDA's permission for its Implantable Eversense Continuous Glucose Monitoring (CGM) system in the US. This long-term system is one of the major discoveries of diabetes devices. The device monitors blood glucose levels for 90 days without the use of lancets and is gaining immense popularity among patients.
Besides this, leading players are focusing on collaborations to expand their regional footprint. For instance, in January 2020, LifeScan, a US-based company entered into collaboration with DKSH, a company specialized in market expansion services, especially in Asia Pacific. With this partnership, DKSH will provide supervisory assistance and distribution and logistics for the sales of LifeScan products in other countries such as Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan.
Some of the leading players operating in the diabetes diagnostics market include Medtronic plc, Abbott Laboratories, F.Hoffmann-La-Ltd., Bayer AG, Lifescan, Inc., B Braun Melsungen AG, Lifescan, Inc., Dexcom Inc., Insulet Corporation, Ypsomed Holdings, Companion Medical, Sanofi, Valeritas Holding Inc., Novo Nordisk, and Arkray, Inc., among others.
The Analyst's Viewpoint
"Companies operating in the market are seeking out opportunities to expand footprint across East and South Asia. As a result they are focusing on launching affordable diabetes supplies to gain competitive edge. Besides this, rising incidence of diabetes will continue supporting the expansion of the market in the region."
COVID-19 Impact on Diabetes Diagnostics Market
Like in other markets, negative impacts of the COVID-19 pandemic are posing numerous challenges to the growth of the diabetes diagnostics market also. Social distancing norms and transportation restrictions imposed by governments have led to a shortage of workers and raw materials. This consequently resulted in disrupting manufacturing activities during the initial phases of the pandemic.
Several international organizations are issuing health advisories to contain the spread of COVID-19. Awareness initiatives undertaken by these organizations are expected to accelerate the market’s growth amid the pandemic crisis. For instance, the International Diabetes Federation has stated that diabetic people are more vulnerable to becoming critically ill if infected by the COVID-19 virus. Hence, growing health awareness and the relation of COVID-19 with diabetes is projected to support the growth of the market.
Diabetes Diagnostics Market- Scope of the Report
A recent study by Fact.MR on the diabetes diagnostics market offers a 10-year forecast for 2020 and 2030. The study analyzes crucial trends that are currently determining the growth of the diabetes diagnostics market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders. The study also provides the dynamics that are responsible for influencing the future status of the diabetes diagnostics market over the forecast period.
A detailed assessment of diabetes diagnostics value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the diabetes diagnostics market along with their product portfolios enhances the reliability of this comprehensive research study.
Diabetes Diagnostics Market: Report Summary
The study offers a comprehensive analysis on diverse features, including demand, product developments, revenue generation, and sales in the diabetes diagnostics market across the globe.
A comprehensive estimate on the diabetes diagnostics market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of diabetes diagnostics during the forecast period. Price point comparison by region with global average price is also considered in the study.
Diabetes Diagnostics Market: Segmentation
Fact.MR has studied the diabetes diagnostics market with detailed segmentation on the basis of by product type, end user, and key region.
Key Questions Answered in Fact.MR’s Diabetes Diagnostics Market Report
- Which regions will continue to remain the most profitable regional markets for diabetes diagnostics market players?
- Which factors will induce a change in the demand for diabetes diagnostics during the assessment period?
- How will changing trends impact the diabetes diagnostics market?
- How can market players capture the low-hanging opportunities in the diabetes diagnostics market in developed regions?
- Which companies are leading the diabetes diagnostics market?
- What are the winning strategies of stakeholders in the diabetes diagnostics market to upscale their position in this landscape?
Diabetes Diagnostics Market: Research Methodology
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the diabetes diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the preparation of diabetes diagnostics market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the diabetes diagnostics market report as a primary resource.
Diabetes Diagnostics Market: Analysis on Market Size Evaluation
The Diabetes diagnostics market has been analyzed for each market segment in terms of value (US$ Mn).
Market estimates at global and regional levels for diabetes diagnostics are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent diabetes diagnostics market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global diabetes diagnostics market.
Diabetes Diagnostics Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the diabetes diagnostics market report, which have helped deliver projections on regional markets. These chapters include regional macros (political economic and business environment outlook), which are expected to have a momentous influence on the growth of the diabetes diagnostics market during the forecast period.
Country-specific valuation on demand for diabetes diagnostics has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value and volume for emerging countries has also been included in the report.
Diabetes Diagnostics Market: In-depth Analysis on Competitive Landscape
The report sheds light on the leading manufacturers of marine adhesives, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of diabetes diagnostics has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status and predicting the competition level in diabetes diagnostics market. Prominent companies operating in the global diabetes diagnostics include Medtronic plc, Abbott Laboratories, F.Hoffmann-La-Ltd., Bayer AG, Lifescan, Inc., B Braun Melsungen AG, Lifescan, Inc., Dexcom Inc., Insulet Corporation, Ypsomed Holdings, Companion Medical, Sanofi, Valeritas Holding Inc., Novo Nordisk, and Arkray, Inc., among others.
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.